United States Biotechnology & Medical Research

WAVE Life Sciences Ltd (WVE)

Track

WAVE Life Sciences Ltd experienced significant insider activity earlier this year. The most recent transactions occurred on March 30, 2026, involving substantial share purchases by RA Capital Management, L.P. Prior to these acquisitions, various company officers engaged in planned and routine sales of shares throughout February and January 2026.
Ticker: WVE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for WAVE Life Sciences Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 30 Mar 2026
Value US$1,768,647.96 | Price 12.85 | Shares 20,170 (+33.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
20,170 +33.2%
12.85
US$1,768,648 		20,170 +33.2% 12.85 US$1,768,648
2026-03-30 2026-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
88,639 -9.3%
438.97
US$2,789,149 		88,639 -9.3% 438.97 US$2,789,149
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
29,227 +22.6%
367.54
US$3,152,905 		29,227 +22.6% 367.54 US$3,152,905
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
4,954,558 +27.2%
6.06
US$30,024,621 		4,954,558 +27.2% 6.06 US$30,024,621
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
15,294 -19.8%
15.00
US$229,410 		15,294 -19.8% 15.00 US$229,410
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -22.4%
15.09
US$270,183 		17,900 -22.4% 15.09 US$270,183
2026-02-11 2026-02-09 S Sale
3.2
BOLNO PAUL

President and CEO

Executive Director
10,480 -3.7%
13.45
US$140,956 		10,480 -3.7% 13.45 US$140,956
2026-02-11 2026-02-09 S Sale
3.2
Francis Chris

See Remarks

Officer
1,883 -3.0%
13.45
US$25,326 		1,883 -3.0% 13.45 US$25,326
2026-02-11 2026-02-09 S Sale
3.2
Vargeese Chandra

See Remarks

Officer
3,228 -0.8%
13.45
US$43,417 		3,228 -0.8% 13.45 US$43,417
2026-02-11 2026-02-09 S Sale
3.2
Moran Kyle

Chief Financial Officer

Officer
3,588 -2.6%
13.45
US$48,259 		3,588 -2.6% 13.45 US$48,259
2026-02-09 2026-02-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
3,564
13.45
US$47,936 		3,564 13.45 US$47,936
2026-02-09 2026-02-09 PrS Proposed sale
3.2
PAUL BOLNO

Officer

Officer
10,411
13.45
US$140,028 		10,411 13.45 US$140,028
2026-02-09 2026-02-09 PrS Proposed sale
3.2
Chris Francis

Officer

Officer
1,870
13.45
US$25,152 		1,870 13.45 US$25,152
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
1,295 -4.9%
16.70
US$21,626 		1,295 -4.9% 16.70 US$21,626
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
8,080 -23.5%
15.92
US$128,634 		8,080 -23.5% 15.92 US$128,634
2025-12-15 2025-12-11 B Purchase
2.3
GSK plc
Large shareholder
1,470,000 +8.8%
19.00
US$27,930,000 		1,470,000 +8.8% 19.00 US$27,930,000
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.6%
20.03
US$1,001,250 		50,000 -35.6% 20.03 US$1,001,250
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
36 -0.0%
20.25
US$729 		36 -0.0% 20.25 US$729
2025-12-09 2025-12-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
86,000
18.52
US$1,592,720 		86,000 18.52 US$1,592,720
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
14.00
US$98,000 		7,000 -13.5% 14.00 US$98,000
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
13.00
US$91,000 		7,000 -13.5% 13.00 US$91,000
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
7,980 -2.8%
14.05
US$112,119 		7,980 -2.8% 14.05 US$112,119
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
12,020 -4.1%
13.09
US$157,342 		12,020 -4.1% 13.09 US$157,342
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
18.00
US$900,000 		50,000 -35.9% 18.00 US$900,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
13.20
US$660,000 		50,000 -35.9% 13.20 US$660,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -26.4%
15.00
US$750,000 		50,000 -26.4% 15.00 US$750,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
60,000 -40.2%
13.20
US$792,000 		60,000 -40.2% 13.20 US$792,000
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
30,000 -70.3%
18.02
US$540,600 		30,000 -70.3% 18.02 US$540,600
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
15,000 -54.2%
14.07
US$211,050 		15,000 -54.2% 14.07 US$211,050
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
42,000 -76.8%
12.75
US$535,500 		42,000 -76.8% 12.75 US$535,500
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
6,445 -33.7%
12.75
US$82,174 		6,445 -33.7% 12.75 US$82,174
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
6,515 -18.4%
14.07
US$91,633 		6,515 -18.4% 14.07 US$91,633
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
9,600 -21.4%
13.09
US$125,664 		9,600 -21.4% 13.09 US$125,664
2025-12-10 2025-12-08 PlS Planned sale
2.9
Rawcliffe Adrian
Non-Executive Director
42,000 -76.8%
15.00
US$630,000 		42,000 -76.8% 15.00 US$630,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
22,500 -47.4%
14.08
US$316,800 		22,500 -47.4% 14.08 US$316,800
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
50,000 -66.7%
16.00
US$800,000 		50,000 -66.7% 16.00 US$800,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
122,349 -83.0%
14.20
US$1,736,744 		122,349 -83.0% 14.20 US$1,736,744
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -41.7%
15.00
US$268,500 		17,900 -41.7% 15.00 US$268,500
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
37,500 -60.0%
14.08
US$528,000 		37,500 -60.0% 14.08 US$528,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
9,375 -27.3%
15.00
US$140,625 		9,375 -27.3% 15.00 US$140,625
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
45,882 -64.7%
14.50
US$665,289 		45,882 -64.7% 14.50 US$665,289
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
107,400 -81.1%
14.56
US$1,563,314 		107,400 -81.1% 14.56 US$1,563,314
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
28,125 -52.9%
14.50
US$407,812 		28,125 -52.9% 14.50 US$407,812
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
25,000 -49.6%
15.00
US$375,000 		25,000 -49.6% 15.00 US$375,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
20,000 -28.4%
12.75
US$255,000 		20,000 -28.4% 12.75 US$255,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
17,230 -40.4%
15.00
US$258,450 		17,230 -40.4% 15.00 US$258,450
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
15,000 -26.0%
12.75
US$191,250 		15,000 -26.0% 12.75 US$191,250
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -22.8%
15.00
US$112,410 		7,494 -22.8% 15.00 US$112,410
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -18.6%
12.75
US$95,548 		7,494 -18.6% 12.75 US$95,548
2025-12-08 2025-12-08 PrS Proposed sale
4.1
Henry Family Trust

Affiliate
93,445
18.52
US$1,730,601 		93,445 18.52 US$1,730,601
2025-12-08 2025-12-08 PrS Proposed sale
HEIDI L WAGNER

Director

Non-Executive Director
14,000
7.49
US$104,860 		14,000 7.49 US$104,860
2025-12-08 2025-12-08 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
210,000
7.49
US$1,572,900 		210,000 7.49 US$1,572,900
2025-12-08 2025-12-08 PrS Proposed sale
3.2
CHRISTOPHER FRANCIS

Officer

Officer
483,602
7.49
US$3,622,179 		483,602 7.49 US$3,622,179
2025-12-08 2025-12-08 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
20,000
7.49
US$149,800 		20,000 7.49 US$149,800
2025-12-08 2025-12-08 PrS Proposed sale
2.9
ADRIAN RAWCLIFFE

Director

Non-Executive Director
42,000
7.49
US$314,580 		42,000 7.49 US$314,580
2025-12-08 2025-12-08 PrS Proposed sale
3.3
MARK CORRIGAN

Director

Non-Executive Director
16,115
7.49
US$120,701 		16,115 7.49 US$120,701
2025-12-08 2025-12-08 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
134,218
13.58
US$1,823,158 		134,218 13.58 US$1,823,158
2025-11-14 2025-11-13 PlS Planned sale
2.9
Rawcliffe Adrian
Non-Executive Director
16,115 -55.9%
6.79
US$109,421 		16,115 -55.9% 6.79 US$109,421
2025-11-14 2025-11-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.0%
6.69
US$6,688 		1,000 +0.0% 6.69 US$6,688
2025-11-13 2025-11-13 PrS Proposed sale
2.9
ADRIAN RAWCLIFFE

Director

Non-Executive Director
16,115
6.96
US$112,080 		16,115 6.96 US$112,080
2025-08-26 2025-08-22 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
10,000 -3.4%
10.00
US$100,000 		10,000 -3.4% 10.00 US$100,000
2025-08-26 2025-08-22 PlS Planned sale
3.2
BOLNO PAUL

President and CEO

Executive Director
217,351 -64.2%
10.10
US$2,194,810 		217,351 -64.2% 10.10 US$2,194,810
2025-08-22 2025-08-22 PrS Proposed sale
3.2
PAUL BOLNO

Director; Officer

Executive Director
217,351
9.76
US$2,121,346 		217,351 9.76 US$2,121,346
2025-08-22 2025-08-22 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
25,000
9.76
US$244,000 		25,000 9.76 US$244,000
2025-08-19 2025-08-15 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -34.2%
9.25
US$194,250 		21,000 -34.2% 9.25 US$194,250
2025-08-15 2025-08-15 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
21,000
9.25
US$194,250 		21,000 9.25 US$194,250
2025-08-13 2025-08-13 PrS Proposed sale
4.1
Christian Henry

Director

Non-Executive Director
9,670
7.70
US$74,459 		9,670 7.70 US$74,459
2025-08-13 2025-08-13 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
9,670 -24.6%
8.81
US$85,193 		9,670 -24.6% 8.81 US$85,193
2025-08-07 2025-08-05 PlS Planned sale
Tan Aik Na
Non-Executive Director
1,127 -7.0%
8.75
US$9,861 		1,127 -7.0% 8.75 US$9,861
2025-08-07 2025-08-05 PlS Planned sale
1.4
TAKANASHI KEN
Non-Executive Director
4,872 -0.1%
8.75
US$42,630 		4,872 -0.1% 8.75 US$42,630
2025-06-13 2025-06-13 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
30,000
7.20
US$216,000 		30,000 7.20 US$216,000
2025-06-13 2025-06-13 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
30,000 -9.6%
6.95
US$208,500 		30,000 -9.6% 6.95 US$208,500
2025-03-21 2025-03-20 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
10,500 -39.5%
9.77
US$102,574 		10,500 -39.5% 9.77 US$102,574
Explore more

More insider trading research around WAVE Life Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America